Ginkgo Bioworks
Cell programming platform company — high-throughput organism design for precision fermentation, biosecurity (biosurveillance), and biological manufacturing across 50+ industry partnerships.
- Country
- United States
- Revenue
- ~$170M
- Employees
- ~700 emp
ISO 9001
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| crop-biotech | ✓ | ✓ | ✓ | ✓ |
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
| enzymes-biocatalysis | ✓ | ✓ | ✓ | ✓ |
| foundries-design | ✓ | ✓ | — | ✓ |
| genome-engineering | ✓ | ✓ | — | ✓ |
| specialty-fine-chem | ✓ | ✓ | — | ✓ |
Regulatorsfdaemanmpaepamoa-chinaefsareachusda-aphis
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biocatalysis in petrochemistry | enzymes-biocatalysis | Low | → |
| Biosynthetic cannabinoids (CBD & THC) | specialty-fine-chem | Medium | → |
| Enzymatic polymer synthesis in vitro | enzymes-biocatalysis | Medium | → |
| Genomic pathogen surveillance (service) | diagnostics-medtech | Medium | → |
| Intelligent genetic switches (kill switches) | genome-engineering | High | → |
| Metabolic engineering | foundries-design | Medium | → |
| Nitrogen-fixing microbial inoculants | crop-biotech | Medium | → |
| Synthetic biology | genome-engineering | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.